Exploring the relationship between homologous recombination score and progression-free survival in BRCA wildtype ovarian carcinoma: Analysis of veliparib plus carboplatin/paclitaxel in the velia study
Year: 2020
Type: article
Source: Gynecologic Oncology
Authors: E.M. Swisher, S.H. Kaufmann, M.J. Birrer, D.A. Levine, K.N. Moore, G.F. Fleming, R.L. Coleman, M.A. Bookman, K.M. Timms, D.M. Sullivan, B.A. Bach, B. Chen, V. Sehgal, P.J. Ansell, M.H. Dinh, C. Aghajanian
Institutions: University of Washington Medical Center, Mayo Clinic, University of Alabama at Birmingham, NYU Langone Health, OU Health Stephenson Cancer Center, University of Chicago, The University of Texas MD Anderson Cancer Center, Kaiser Permanente Northern California, Myriad Genetics, AbbVie (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3014107376